AI assistant
Sending…
DEXCOM INC — Director's Dealing 2019
Feb 15, 2019
30198_dirs_2019-02-15_a37731fe-7336-4957-9ba5-d46eb06713f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-12-31
Reporting Person: Collins Richard Alexander (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-01 | Common Stock | J | 5355 | $0.0 | Disposed | 3949 | Direct |
| 2018-06-01 | Common Stock | J | 5355 | $0.0 | Acquired | 5355 | Indirect |
Footnotes
F1: Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17